1. From the University of Birmingham Centre for Cardiovascular Sciences (G.Y.H.L., D.A.L.), City Hospital, Birmingham, England, UK; AstraZeneca R&D Mölndal (L.F.), Mölndal, Sweden; The Cardiovascular Institute (J.L.H.), Mount Sinai Medical Center, New York, NY.